HIV Drug Resistance Program Conference: Host Factors and Cofactors in
February 25, 2014 (rescheduled from October 16, 2013 due to the government shutdown)
Building 549 Conference Center
We are pleased to announce that the HIV Drug Resistance Program Conference: Host Factors and Cofactors in HIV Infection will be held the afternoon of February 25, 2014 at the National Cancer Institute (NCI) campus in Frederick, Maryland. The HIV Drug Resistance Program, Center for Cancer Research (CCR) is sponsoring this conference with support from the CCR Center of Excellence in HIV/AIDS & Cancer Virology and the NCI Office of HIV and AIDS Malignancy to showcase the latest findings on host factors and cofactors in HIV infection. Understanding the interplay of HIV with both positively and negatively restricting cellular proteins, as well as the influence of cofactors in the etiology of HIV infection, will lead to new insights into the mechanisms involved in the pathogenesis of HIV disease.
Invited speakers in the outstanding program include Michael Emerman (Fred Hutchinson Cancer Research Center), John Guatelli (University of California San Diego and the VA San Diego Healthcare System), Welkin Johnson (Boston College), Jacek Skowronski (Case Western Reserve University), and Yong Xiong (Yale University). In addition to research presentations by these distinguished scientists, the conference will conclude with a round-table discussion addressing future developments and opportunities for antiviral strategies and insights into novel mechanisms of carcinogenesis.
We hope you will be able to join us at the HIV Drug Resistance Program Conference: Host Factors and Cofactors in HIV Infection on February 25.
Stephen H. Hughes, Ph.D.
HIV Drug Resistance Program, CCR, NCI
Robert Yarchoan, M.D.
Office of HIV and AIDS Malignancy, NCI
Stuart F.J. Le Grice, Ph.D.
Center of Excellence in HIV/AIDS & Cancer Virology, CCR, NCI